Contrast Media Contrast Agent Market : Market Size, Trends, Key Players and Forecast
According to the new market research report Contrast Media Contrast Agent Market
by Type (Iodinated Contrast Media), Modality (X-Ray/CT, MRI, and
Ultrasound), Application (Radiology), End User (Hospitals), Indication
(Cancer), Route of Administration (Oral), Region - Global Forecast to
2026, published by MarketsandMarkets™, the global Contrast Media Market
is projected to USD 5.9 billion by 2026 from USD 4.9 billion in 2021, at
a CAGR of 3.7% during the forecast period.
Browse in-depth TOC on "Contrast Media Contrast Agent Market"
328 – Tables
39 – Figures
299 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911
The Rising prevalence of chronic diseases, growing approvals of
contrast agents, rising volume of CT and MRI examinations performed,
growing number of diagnostic centers and hospitals, and availability of
reimbursement are the major factors driving the growth of the contrast
agents market.
The microbubble contrast media segment
is expected to grow at the highest CAGR during the forecast period and
iodinated contrast media accounted for the largest share in 2020.
Based on type, the Contrast Media Contrast Agent Market is segmented
into iodinated contrast media, gadolinium-based contrast media,
microbubble contrast media, and barum-based contrast media. Iodinated
contrast media account for the largest share of the market. The large
share of this segment can be attributed to the growing number of
angioplasty procedures performed globally.
North America was the largest regional market for the contrast agents market in 2020
The contrast media market is segmented into five major regions, namely,
North America, Europe, Asia Pacific, Latin America and the Middle East
& Africa (MEA). North America was the largest regional market in
2020. The large share of the North American market can be attributed to
presence of major players in the region, high prevalence of chronic
disorders, growing geriatric population, and the increasing adoption of
minimally invasive procedures.
However, the Asia Pacific
Contrast Media Contrast Agent Market is estimated to grow at the highest
CAGR during the forecast period. The rising prevalence of chronic
diseases, the growing demand for quality medical care, increasing
healthcare spending and government initiatives, rising disposable
income, growth in the medical device industries, and improvements in
healthcare infrastructure in Southeast Asian countries are the major
factors driving the growth of the market in the Asia Pacific.
Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=911
The global Contrast Media Contrast Agent Market
is consolidated. The prominent players operating in this market include
GE Healthcare (US), Bracco Imaging SPA (Italy), Bayer AG (Germany),
Guerbet (France), J.B. Chemicals and Pharmaceuticals Ltd. (India),
Lantheus Medical Imaging, Inc. (US), Unijules Life Sciences Ltd.
(India), and SANOCHEMIA Pharmazeutika GmbH (Austria).
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Comments
Post a Comment